We further investigated the subcellular localization of phosphorylated SRPK2 upon IGF- 1 exposure by performing cell fractionation in which breast cancer cells were treated with a vehicle or rapamycin and exposed to IGF-1. The gene discussed is IGF1; the disease is breast carcinoma.